Scientists Explore How T Cells Identify and Respond to Various Influenza A Virus Variants
Nikhil Prasad Fact checked by:Thailand Medical News Team Feb 20, 2025 1 day, 6 hours, 31 minutes ago
Medical News: A team of researchers from multiple global institutions has conducted an in-depth study on how certain immune cells, known as T cells, can recognize and respond to different strains of the influenza A virus. This discovery could have significant implications for the development of more effective vaccines that offer broad protection against various flu strains.
Scientists Explore How T Cells Identify and Respond to Various Influenza A Virus Variants
This
Medical News report highlights how the study examined T cell receptors (TCRs) that can recognize multiple influenza A virus variants. The researchers focused on a specific immune response involving CD8+ T cells, which play a crucial role in the body's ability to fight off viral infections. The study provides a deeper understanding of why some individuals may develop stronger immunity against different strains of the flu virus over time, while others remain more vulnerable.
Research Institutions Involved in the Study
The study was conducted by scientists from leading institutions, including the Peter Doherty Institute for Infection and Immunity at the University of Melbourne, the Biomedicine Discovery Institute at Monash University in Australia, the Washington University School of Medicine in St. Louis, USA, the Research Center for Emerging Infections and Zoonoses at the University of Veterinary Medicine in Hannover, Germany, and the Institute of Infection and Immunity at Cardiff University in the United Kingdom.
Investigating T Cell Cross-Reactivity
The research team analyzed how T cell receptors (TCRs) respond to different influenza A virus strains by screening 12 naturally occurring variations of a key viral protein called nucleoprotein (NP418). This protein has been present in influenza A strains dating back to 1918, including the recent 2024 H5N1 avian influenza virus.
The study found that some TCRs are capable of recognizing a broad range of these NP418 variants. However, this broad recognition came with a trade-off: the T cells that were more cross-reactive had reduced antigen sensitivity, meaning they required a stronger stimulus to become fully activated. This finding suggests that while some TCRs can recognize many virus strains, their ability to mount a strong immune response may be weaker than TCRs that are more specific to a single variant.
Key Findings of the Study
-TCR Cross-Reactivity – The study identified certain CD8+ T cells that could recognize multiple variants of the NP418 epitope. These cross-reactive T cells were found to target conserved regions of the virus while avoiding more variable positions, allowing them to respond to different strains.
-Reduced Antigen Sensitivity – While these cross-reactive T cells recognized multiple virus strains, they required a stronger signal to become activated, indicating lower antigen sensitivity.
-Str
uctural Insights – The researchers used advanced structural analysis to determine how these T cells interact with the virus. They found that the TCRs maintained contact with stable, unchanging parts of the NP418 protein, enabling them to recognize different viral variants.
-CD8 Coreceptor Dependence – The study also revealed that the activation of cross-reactive CD8+ T cells was strongly dependent on CD8 coreceptor binding. When this coreceptor was absent, the cross-reactivity of these T cells was significantly reduced.
-Potential for Universal Flu Vaccines – Understanding how these T cells recognize different influenza A strains could contribute to the development of a universal flu vaccine that offers protection against multiple strains, reducing the need for yearly flu shots.
How the Study Was Conducted
To reach these conclusions, the researchers used a combination of experimental approaches, including:
-Screening 12 naturally occurring NP418 variants to determine the extent of T cell recognition.
-Using high-resolution structural analysis to understand how TCRs bind to different viral proteins.
-Generating primary human CD8+ T cell lines to measure immune responses in a controlled laboratory setting.
-Employing engineered Jurkat-TCR transfectants to define recognition across several viral variants.
-Conducting statistical analyses to compare different TCR responses and antigen sensitivities.
Implications for Future Flu Vaccines
The findings of this study offer valuable insights into the design of more effective influenza vaccines. Currently, flu vaccines are designed based on predictions of which strains are likely to be dominant in a given flu season. However, influenza viruses mutate rapidly, often reducing the effectiveness of annual vaccines.
By identifying T cells that can recognize multiple influenza variants, scientists may be able to develop a vaccine that provides broader and longer-lasting immunity. A universal flu vaccine that targets conserved viral regions, rather than strain-specific proteins, could offer better protection against emerging flu strains and even pandemic threats.
Conclusion
This groundbreaking research sheds light on the molecular mechanisms of T cell recognition and cross-reactivity, paving the way for new approaches to combating influenza. The study highlights how some T cells can recognize multiple influenza variants, though at the cost of reduced antigen sensitivity. These findings could be instrumental in the development of next-generation vaccines that offer broader protection against seasonal and pandemic flu viruses.
The study findings were published in the peer-reviewed journal: Science Immunology.
https://www.science.org/doi/10.1126/sciimmunol.adn3805
For the latest Influenza News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/elderberry-extract-and-quinine-show-promising-antiviral-potential-against-influenza-and-covid-19
https://www.thailandmedical.news/news/new-study-unveils-how-influenza-virus-exploits-cxcl8-mapk-hnrnp-k-pathway-to-enhance-infection
https://www.thailandmedical.news/news/an-update-on-approved-and-innovative-therapeutic-approaches-to-combatting-influenza-viruses
https://www.thailandmedical.news/articles/influenza-or-flu
https://www.thailandmedical.news/articles/h5n1-avian-flu
https://www.thailandmedical.news/pages/thailand_doctors_listings
Share
Tweet
Share
